HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for.
The data collected from the usage and experience of the medical professionals in the formative study will be used to support the Company s anticipated milestonesHINGHAM, Mass., May 31, 2023 . | May 31, 2023
Microbot Medical Inc. (NASDAQ:MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERTY surgical robotic system.
This Significant Achievement Represents Major Progression Toward Regulatory and Commercialization Paths Additional Sites in the U.S. Are Expected to Participate in the Trial HINGHAM, Mass., May 25,. | May 25, 2023